Veradermics is trading 4.41% up at $102.80, with sector strength the clearest explanation; biotech ETF XBI is up 2.06% during regular trading.
- The stock recovered from the August 24, 2026 close of $98.46.
- Recent insider selling disclosed August 24 pressured the prior session.
- No new company-specific catalyst was identified for August 25, 2026; the latest earnings update remains dated August 11, 2026.